How Investors May Respond To Viavi Solutions (VIAV) Army Test Range Win

• Calnex Solutions and the U.S. Army recently highlighted Viavi Solutions, with Calnex expanding its test partnership and the Army selecting Viavi's T/Rx transceiver to recreate complex electromagnetic spectrum conditions at newly opened test ranges.
• These moves deepen Viavi Solutions' role in defense-oriented testing and lab-based network emulation, which speaks directly to demand for its higher value, mission critical test and measurement platforms.
• We will now examine how Viavi Solutions' investment narrative could be influenced by the U.S. Army's adoption of its T/Rx system.

Scan beyond Viavi Solutions and line up other defense and network test plays by reviewing the hand picked 32 resilient stocks with low risk scores that fit a similar mission critical profile.

Viavi Solutions Investment Narrative Recap

To own Viavi Solutions, you need to believe its test and measurement portfolio can convert demand in data centers, fiber, aerospace, and defense into a sustained, higher quality earnings stream. In the short term, the key swing factor remains execution on large network and data center projects while managing an unprofitable base business and a P/S multiple that screens above the broader US Communications group.

On the risk side, delayed wireless and service provider spending, dependence on more volatile funding sources, and ongoing integration work around recent deals remain front of mind. The recent defense wins are helpful, but they do not remove exposure to supply chain disruption, telecom cyclicality, or the need to reach the profitability targets analysts are modeling.

The U.S. Army selection of the Viavi T/Rx software defined transceiver is the clearest recent proof point for the aerospace and defense push that analysts already highlight as a key catalyst. It ties Viavi hardware and software into test ranges used by a wide set of private developers, which broadens touch points across drones, counter drone tools, and other electronic warfare systems.

Operationally, that kind of deployment leans into Viavi Solutions strengths in mission critical test gear, but it still has to coexist with softer wireless infrastructure demand and lumpy carrier budgets. Investors watching this contract may focus on two things: how reliably the company can support complex electromagnetic spectrum testing at scale, and whether that performance leads to a thicker pipeline of defense oriented lab and field projects.

Viavi Solutions' current analyst narrative points to forecast 2029 revenue of US$2.5b and projected earnings of US$503.0 million by that year, based on an assumed 18.0% yearly top line growth rate and an earnings shift from a loss of US$30.4 million today to that US$503.0 million figure. This represents an earnings increase of about US$533 million over the period.

Uncover why Viavi Solutions' fair value indicates a 76% potential upside to its current price, which could narrow quickly.

Exploring Other Perspectives

You are seeing one clear tension around Viavi Solutions. The baseline view leans on aerospace and defense as a smoother revenue mix, while the more cautious analysts worry that government program timing could stay lumpy. Those bearish forecasts still penciled in about US$2.5b of 2029 revenue and US$524.5 million of earnings before this Army T/Rx news, so opinions may shift as new data lands.

Explore 3 other Viavi Solutions fair value estimates, including one that suggests as much as 19% downside from the current price.

Form Your Own Verdict

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

• A great starting point for your Viavi Solutions research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• See our latest analysis for Viavi Solutions. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Viavi Solutions' overall financial health at a glance.

Looking for more investment ideas beyond Viavi Solutions?

Once you have a view on Viavi Solutions, it often helps to widen the lens and compare it with other companies that fit different risk, income, and balance sheet profiles. The Simply Wall St Screener can help you surface focused shortlists in a few clicks.

• If you want potential growth with strict risk filters, start with a curated set of resilient companies in the 32 resilient stocks with low risk scores.
• For investors who prioritize strong finances and staying power, scan the list of solid balance sheet and fundamentals (25 results) to see which businesses clear a higher quality bar.
• If you are hunting for underappreciated opportunities with healthier fundamentals, the 20 high quality undiscovered gems can surface stocks that are not yet widely followed.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com